NasdaqGS - Delayed Quote • USD
Arcutis Biotherapeutics, Inc. (ARQT)
At close: 4:00 PM EDT
After hours: 6:42 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 1,206,786 | 17 |
Sales | 32,553 | 7 |
Net Shares Purchased (Sold) | 1,174,233 | 24 |
Total Insider Shares Held | 2.42M | -- |
% Net Shares Purchased (Sold) | 94.50% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
TOPPER DAVID JOSEPH Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 10, 2024 |
HERON PATRICK J Director | Purchase at price 9.50 per share. | Indirect | 199,994 | Mar 4, 2024 |
BURNETT PATRICK Officer | Sale at price 11.12 per share. | Direct | 53,182 | Mar 4, 2024 |
MATSUDA MASARU General Counsel | Sale at price 11.12 per share. | Direct | 41,816 | Mar 4, 2024 |
WATANABE TODD FRANKLIN Chief Executive Officer | Sale at price 11.12 per share. | Direct | 165,739 | Mar 4, 2024 |
MOORE MATTHEW RICHARD Officer | Sale at price 11.12 per share. | Direct | 38,568 | Mar 4, 2024 |
WATANABE TODD FRANKLIN Chief Executive Officer | Sale at price 10.60 per share. | Direct | 26,129 | Feb 28, 2024 |
SMITHER JOHN W Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 13, 2024 |
BURNETT PATRICK Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 13, 2024 |
MATSUDA MASARU General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 13, 2024 |
WATANABE TODD FRANKLIN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 13, 2024 |
MOORE MATTHEW RICHARD Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 13, 2024 |
BURNETT PATRICK Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 12, 2024 |
MATSUDA MASARU General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 12, 2024 |
WATANABE TODD FRANKLIN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 12, 2024 |
MOORE MATTHEW RICHARD Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 12, 2024 |
EDWARDS LARRY TODD Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 12, 2024 |
BURNETT PATRICK Officer | Sale at price 3.54 per share. | Direct | 4,692 | Jan 2, 2024 |
WATANABE TODD FRANKLIN Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 20, 2023 |
WATANABE TODD FRANKLIN Chief Executive Officer | Conversion of Exercise of derivative security at price 1.68 per share. | Direct | 100,038 | Dec 1, 2023 |
MATSUDA MASARU General Counsel | Sale at price 1.98 per share. | Direct | 3,661 | Nov 21, 2023 |
MATSUDA MASARU General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 17, 2023 |
FRAZIER LIFE SCIENCES VIII, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.50 per share. | Direct | 200,000 | Oct 24, 2023 |
EDWARDS LARRY TODD Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 27, 2023 |
BURNETT PATRICK Officer | Sale at price 7.04 - 7.05 per share. | Direct | 11,302 | Aug 21, 2023 |
HERON PATRICK J Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2023 |
LEONARD KEITH R JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2023 |
GILBERT HALLEY E Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2023 |
CURRAN TERRIE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2023 |
MATSUDA MASARU General Counsel | Stock Award(Grant) at price 0.00 - 6.38 per share. | Direct | 9,334 | May 31, 2023 |
MATSUDA MASARU General Counsel | Sale at price 7.80 per share. | Direct | 14,278 | May 31, 2023 |
WATANABE TODD FRANKLIN Chief Executive Officer | Purchase at price 6.38 per share. | Direct | 9,334 | May 31, 2023 |
CHAUDHURI BHASKAR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2023 |
WELGUS HOWARD G Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2023 |
KRISHNAMOHAN NEHA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2023 |
LIN SUE-JEAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2023 |
WELGUS HOWARD G Director | Sale at price 13.97 per share. | Direct | 118,728 | Apr 17, 2023 |
WELGUS HOWARD G Director | Conversion of Exercise of derivative security at price 1.68 per share. | Direct | 14,285 | Apr 17, 2023 |
WELGUS HOWARD G Director | Sale at price 12.01 per share. | Direct | 102,085 | Apr 6, 2023 |
WELGUS HOWARD G Director | Conversion of Exercise of derivative security at price 1.68 per share. | Direct | 14,285 | Apr 6, 2023 |
OSBORNE DAVID W Chief Technology Officer | Sale at price 15.26 per share. | Direct | 10,532 | Mar 6, 2023 |
BURNETT PATRICK Officer | Sale at price 15.26 per share. | Direct | 12,989 | Mar 6, 2023 |
WATANABE TODD FRANKLIN Chief Executive Officer | Sale at price 15.26 per share. | Direct | 37,167 | Mar 6, 2023 |
LOCK KENNETH A Officer | Sale at price 15.26 per share. | Direct | 12,684 | Mar 6, 2023 |
TURNEY PATRICIA A Officer | Sale at price 15.26 per share. | Direct | 12,684 | Mar 6, 2023 |
BURROWS SCOTT L. Chief Financial Officer | Sale at price 15.26 per share. | Direct | 4,442 | Mar 6, 2023 |
OSBORNE DAVID W Chief Technology Officer | Sale at price 15.82 - 16.52 per share. | Direct | 32,002 | Mar 2, 2023 |
OSBORNE DAVID W Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 2, 2023 |
BURNETT PATRICK Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 2, 2023 |
BURNETT PATRICK Officer | Sale at price 15.82 - 16.52 per share. | Direct | 27,713 | Mar 2, 2023 |
Related Tickers
CCCC C4 Therapeutics, Inc.
6.72
-2.75%
DAWN Day One Biopharmaceuticals, Inc.
14.96
-5.02%
PHAT Phathom Pharmaceuticals, Inc.
8.97
-5.38%
RNA Avidity Biosciences, Inc.
22.73
-1.35%
ALLO Allogene Therapeutics, Inc.
3.4700
+0.29%
CGEM Cullinan Therapeutics, Inc.
15.66
-13.29%
TSVT 2seventy bio, Inc.
4.5200
-2.59%
XFOR X4 Pharmaceuticals, Inc.
1.2600
+5.00%
SANA Sana Biotechnology, Inc.
7.61
-1.55%
EYEN Eyenovia, Inc.
0.5706
+7.48%